APO Research
Talk to an analyst

APO RESEARCH · REPORT

Beraprost Sodium

Compare research editions
View pricing & licenses

Selected research

Industry Research

Beraprost Sodium Industry Research Report 2026

20 December 2025134 pages

Choose your research edition.

Industry ResearchBeraprost Sodium Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Beraprost Sodium Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Beraprost Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Beraprost Sodium Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Beraprost Sodium Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Beraprost Sodium market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Beraprost Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Beraprost Sodium is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Beraprost Sodium is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Beraprost Sodium include Teva, Daiichi Sankyo Co Ltd, Yoshindo, Viatris, Toray, Taide Pharma, Shin Poong Pharmaceutical, Sawai Pharmaceutical and Ohara Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Beraprost Sodium market in terms of revenue (US$ million) and, where applicable, sales volume (k pcs), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k pcs) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Beraprost Sodium Market by Company

Teva

Daiichi Sankyo Co Ltd

Yoshindo

Viatris

Toray

Taide Pharma

Shin Poong Pharmaceutical

Sawai Pharmaceutical

Ohara Inc

Nihon Generic Co Ltd

Nichiiko

NABIQASIM INDUSTRIES

Lupin Laboratories

KYOUSOUMIRAI PHARM

Kyorin Holding

Kaken Pharmaceutical

Astellas Pharma

Alfresa Pharma

Beraprost Sodium Segment by Type

Tablet

Sustained Release Tablets

Beraprost Sodium Segment by Application

Hospital

Clinic

Beraprost Sodium Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Beraprost Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Beraprost Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Beraprost Sodium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Beraprost Sodium manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Beraprost Sodium by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Beraprost Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Beraprost Sodium Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Beraprost Sodium Sales (k pcs) of Manufacturers (2021-2026) Table 7. Global Beraprost Sodium Sales Market Share by Manufacturers (2021-2026) Table 8. Global Beraprost Sodium Revenue of Manufacturers (2021-2026) Table 9. Global Beraprost Sodium Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Beraprost Sodium Average Price (US$/pcs) of Manufacturers (2021-2026) Table 11. Global Beraprost Sodium Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Beraprost Sodium, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Beraprost Sodium, Product Type & Application Table 14. Global Beraprost Sodium Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Beraprost Sodium by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Teva Company Information Table 19. Teva Business Overview Table 20. Teva Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 21. Teva Beraprost Sodium Product Portfolio Table 22. Teva Recent Developments Table 23. Daiichi Sankyo Co Ltd Company Information Table 24. Daiichi Sankyo Co Ltd Business Overview Table 25. Daiichi Sankyo Co Ltd Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 26. Daiichi Sankyo Co Ltd Beraprost Sodium Product Portfolio Table 27. Daiichi Sankyo Co Ltd Recent Developments Table 28. Yoshindo Company Information Table 29. Yoshindo Business Overview Table 30. Yoshindo Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 31. Yoshindo Beraprost Sodium Product Portfolio Table 32. Yoshindo Recent Developments Table 33. Viatris Company Information Table 34. Viatris Business Overview Table 35. Viatris Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 36. Viatris Beraprost Sodium Product Portfolio Table 37. Viatris Recent Developments Table 38. Toray Company Information Table 39. Toray Business Overview Table 40. Toray Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 41. Toray Beraprost Sodium Product Portfolio Table 42. Toray Recent Developments Table 43. Taide Pharma Company Information Table 44. Taide Pharma Business Overview Table 45. Taide Pharma Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 46. Taide Pharma Beraprost Sodium Product Portfolio Table 47. Taide Pharma Recent Developments Table 48. Shin Poong Pharmaceutical Company Information Table 49. Shin Poong Pharmaceutical Business Overview Table 50. Shin Poong Pharmaceutical Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 51. Shin Poong Pharmaceutical Beraprost Sodium Product Portfolio Table 52. Shin Poong Pharmaceutical Recent Developments Table 53. Sawai Pharmaceutical Company Information Table 54. Sawai Pharmaceutical Business Overview Table 55. Sawai Pharmaceutical Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 56. Sawai Pharmaceutical Beraprost Sodium Product Portfolio Table 57. Sawai Pharmaceutical Recent Developments Table 58. Ohara Inc Company Information Table 59. Ohara Inc Business Overview Table 60. Ohara Inc Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 61. Ohara Inc Beraprost Sodium Product Portfolio Table 62. Ohara Inc Recent Developments Table 63. Nihon Generic Co Ltd Company Information Table 64. Nihon Generic Co Ltd Business Overview Table 65. Nihon Generic Co Ltd Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 66. Nihon Generic Co Ltd Beraprost Sodium Product Portfolio Table 67. Nihon Generic Co Ltd Recent Developments Table 68. Nichiiko Company Information Table 69. Nichiiko Business Overview Table 70. Nichiiko Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 71. Nichiiko Beraprost Sodium Product Portfolio Table 72. Nichiiko Recent Developments Table 73. NABIQASIM INDUSTRIES Company Information Table 74. NABIQASIM INDUSTRIES Business Overview Table 75. NABIQASIM INDUSTRIES Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 76. NABIQASIM INDUSTRIES Beraprost Sodium Product Portfolio Table 77. NABIQASIM INDUSTRIES Recent Developments Table 78. Lupin Laboratories Company Information Table 79. Lupin Laboratories Business Overview Table 80. Lupin Laboratories Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 81. Lupin Laboratories Beraprost Sodium Product Portfolio Table 82. Lupin Laboratories Recent Developments Table 83. KYOUSOUMIRAI PHARM Company Information Table 84. KYOUSOUMIRAI PHARM Business Overview Table 85. KYOUSOUMIRAI PHARM Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 86. KYOUSOUMIRAI PHARM Beraprost Sodium Product Portfolio Table 87. KYOUSOUMIRAI PHARM Recent Developments Table 88. Kyorin Holding Company Information Table 89. Kyorin Holding Business Overview Table 90. Kyorin Holding Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 91. Kyorin Holding Beraprost Sodium Product Portfolio Table 92. Kyorin Holding Recent Developments Table 93. Kaken Pharmaceutical Company Information Table 94. Kaken Pharmaceutical Business Overview Table 95. Kaken Pharmaceutical Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 96. Kaken Pharmaceutical Beraprost Sodium Product Portfolio Table 97. Kaken Pharmaceutical Recent Developments Table 98. Astellas Pharma Company Information Table 99. Astellas Pharma Business Overview Table 100. Astellas Pharma Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 101. Astellas Pharma Beraprost Sodium Product Portfolio Table 102. Astellas Pharma Recent Developments Table 103. Alfresa Pharma Company Information Table 104. Alfresa Pharma Business Overview Table 105. Alfresa Pharma Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 106. Alfresa Pharma Beraprost Sodium Product Portfolio Table 107. Alfresa Pharma Recent Developments Table 108. Global Beraprost Sodium Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global Beraprost Sodium Sales by Region (2021-2026) & (k pcs) Table 110. Global Beraprost Sodium Sales Market Share by Region (2021-2026) Table 111. Global Beraprost Sodium Sales by Region (2027-2032) & (k pcs) Table 112. Global Beraprost Sodium Sales Market Share by Region (2027-2032) Table 113. Global Beraprost Sodium Revenue by Region (2021-2026) & (US$ Million) Table 114. Global Beraprost Sodium Revenue Market Share by Region (2021-2026) Table 115. Global Beraprost Sodium Revenue by Region (2027-2032) & (US$ Million) Table 116. Global Beraprost Sodium Revenue Market Share by Region (2027-2032) Table 117. North America Beraprost Sodium Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America Beraprost Sodium Sales by Country (2021-2026) & (k pcs) Table 119. North America Beraprost Sodium Sales by Country (2027-2032) & (k pcs) Table 120. North America Beraprost Sodium Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Beraprost Sodium Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe Beraprost Sodium Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe Beraprost Sodium Sales by Country (2021-2026) & (k pcs) Table 124. Europe Beraprost Sodium Sales by Country (2027-2032) & (k pcs) Table 125. Europe Beraprost Sodium Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Beraprost Sodium Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific Beraprost Sodium Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific Beraprost Sodium Sales by Country (2021-2026) & (k pcs) Table 129. Asia Pacific Beraprost Sodium Sales by Country (2027-2032) & (k pcs) Table 130. Asia Pacific Beraprost Sodium Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific Beraprost Sodium Revenue by Country (2027-2032) & (US$ Million) Table 132. South America Beraprost Sodium Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America Beraprost Sodium Sales by Country (2021-2026) & (k pcs) Table 134. South America Beraprost Sodium Sales by Country (2027-2032) & (k pcs) Table 135. South America Beraprost Sodium Revenue by Country (2021-2026) & (US$ Million) Table 136. South America Beraprost Sodium Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Beraprost Sodium Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa Beraprost Sodium Sales by Country (2021-2026) & (k pcs) Table 139. Middle East and Africa Beraprost Sodium Sales by Country (2027-2032) & (k pcs) Table 140. Middle East and Africa Beraprost Sodium Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Beraprost Sodium Revenue by Country (2027-2032) & (US$ Million) Table 142. Global Beraprost Sodium Sales by Type (2021-2026) & (k pcs) Table 143. Global Beraprost Sodium Sales by Type (2027-2032) & (k pcs) Table 144. Global Beraprost Sodium Sales Market Share by Type (2021-2026) Table 145. Global Beraprost Sodium Sales Market Share by Type (2027-2032) Table 146. Global Beraprost Sodium Revenue by Type (2021-2026) & (US$ Million) Table 147. Global Beraprost Sodium Revenue by Type (2027-2032) & (US$ Million) Table 148. Global Beraprost Sodium Revenue Market Share by Type (2021-2026) Table 149. Global Beraprost Sodium Revenue Market Share by Type (2027-2032) Table 150. Global Beraprost Sodium Price by Type (2021-2026) & (US$/pcs) Table 151. Global Beraprost Sodium Price by Type (2027-2032) & (US$/pcs) Table 152. Global Beraprost Sodium Sales by Application (2021-2026) & (k pcs) Table 153. Global Beraprost Sodium Sales by Application (2027-2032) & (k pcs) Table 154. Global Beraprost Sodium Sales Market Share by Application (2021-2026) Table 155. Global Beraprost Sodium Sales Market Share by Application (2027-2032) Table 156. Global Beraprost Sodium Revenue by Application (2021-2026) & (US$ Million) Table 157. Global Beraprost Sodium Revenue by Application (2027-2032) & (US$ Million) Table 158. Global Beraprost Sodium Revenue Market Share by Application (2021-2026) Table 159. Global Beraprost Sodium Revenue Market Share by Application (2027-2032) Table 160. Global Beraprost Sodium Price by Application (2021-2026) & (US$/pcs) Table 161. Global Beraprost Sodium Price by Application (2027-2032) & (US$/pcs) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Beraprost Sodium Distributors List Table 165. Beraprost Sodium Customers List Table 166. Beraprost Sodium Industry Trends Table 167. Beraprost Sodium Industry Drivers Table 168. Beraprost Sodium Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Beraprost Sodium Product Image Figure 5. Global Beraprost Sodium Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Beraprost Sodium Market Size (2021-2032) & (US$ Million) Figure 7. Global Beraprost Sodium Sales (2021-2032) & (k pcs) Figure 8. Global Beraprost Sodium Average Price (US$/pcs) & (2021-2032) Figure 9. Tablet Product Image Figure 10. Sustained Release Tablets Product Image Figure 11. Hospital Product Image Figure 12. Clinic Product Image Figure 13. Global Beraprost Sodium Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Beraprost Sodium, Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Beraprost Sodium Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Beraprost Sodium Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Beraprost Sodium Sales by Region in 2025 Figure 19. Global Beraprost Sodium Revenue by Region in 2025 Figure 20. North America Beraprost Sodium Market Size by Country in 2025 Figure 21. North America Beraprost Sodium Sales Market Share by Country (2021-2032) Figure 22. North America Beraprost Sodium Revenue Market Share by Country (2021-2032) Figure 23. United States Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Mexico Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Beraprost Sodium Market Size by Country in 2025 Figure 27. Europe Beraprost Sodium Sales Market Share by Country (2021-2032) Figure 28. Europe Beraprost Sodium Revenue Market Share by Country (2021-2032) Figure 29. Germany Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Russia Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Spain Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Switzerland Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Sweden Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Poland Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Beraprost Sodium Market Size by Country in 2025 Figure 40. Asia Pacific Beraprost Sodium Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Beraprost Sodium Revenue Market Share by Country (2021-2032) Figure 42. China Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Taiwan Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Beraprost Sodium Market Size by Country in 2025 Figure 51. South America Beraprost Sodium Sales Market Share by Country (2021-2032) Figure 52. South America Beraprost Sodium Revenue Market Share by Country (2021-2032) Figure 53. Brazil Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Argentina Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Chile Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa Beraprost Sodium Market Size by Country in 2025 Figure 57. Middle East and Africa Beraprost Sodium Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa Beraprost Sodium Revenue Market Share by Country (2021-2032) Figure 59. Egypt Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. South Africa Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Israel Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Türkiye Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. GCC Countries Beraprost Sodium Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Global Beraprost Sodium Sales Market Share by Type (2021-2032) Figure 65. Global Beraprost Sodium Revenue Market Share by Type (2021-2032) Figure 66. Global Beraprost Sodium Price (US$/pcs) by Type (2021-2032) Figure 67. Global Beraprost Sodium Sales Market Share by Application (2021-2032) Figure 68. Global Beraprost Sodium Revenue Market Share by Application (2021-2032) Figure 69. Global Beraprost Sodium Price (US$/pcs) by Application (2021-2032) Figure 70. Beraprost Sodium Value Chain Figure 71. Beraprost Sodium Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Beraprost Sodium Industry Opportunities and Challenges

Scope & coverage.

Types
  • Tablet
  • Sustained Release Tablets
Applications
  • Hospital
  • Clinic
Companies covered
  • Teva
  • Daiichi Sankyo Co Ltd
  • Yoshindo
  • Viatris
  • Toray
  • Taide Pharma
  • Shin Poong Pharmaceutical
  • Sawai Pharmaceutical
  • Ohara Inc
  • Nihon Generic Co Ltd
  • Nichiiko
  • NABIQASIM INDUSTRIES
  • Lupin Laboratories
  • KYOUSOUMIRAI PHARM
  • Kyorin Holding
  • Kaken Pharmaceutical
  • Astellas Pharma
  • Alfresa Pharma

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Beraprost Sodium Market Size (2021-2032)
  4. 2.2.2 Global Beraprost Sodium Sales (2021-2032)
  5. 2.2.3 Global Beraprost Sodium Market Average Price (2021-2032)
  6. 2.3 Beraprost Sodium by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Tablet
  9. 2.3.3 Sustained Release Tablets
  10. 2.4 Beraprost Sodium by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Beraprost Sodium Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Beraprost Sodium Sales (k pcs) of Manufacturers (2021-2026)
  3. 3.3 Global Beraprost Sodium Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Beraprost Sodium Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Beraprost Sodium Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Beraprost Sodium, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Beraprost Sodium, Product Type & Application
  8. 3.8 Global Manufacturers of Beraprost Sodium, Established Date
  9. 3.9 Global Beraprost Sodium Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Teva
  2. 4.1.1 Teva Company Information
  3. 4.1.2 Teva Business Overview
  4. 4.1.3 Teva Beraprost Sodium Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Teva Beraprost Sodium Product Portfolio
  6. 4.1.5 Teva Recent Developments
  7. 4.2 Daiichi Sankyo Co Ltd
  8. 4.2.1 Daiichi Sankyo Co Ltd Company Information
  9. 4.2.2 Daiichi Sankyo Co Ltd Business Overview
  10. 4.2.3 Daiichi Sankyo Co Ltd Beraprost Sodium Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Daiichi Sankyo Co Ltd Beraprost Sodium Product Portfolio
  12. 4.2.5 Daiichi Sankyo Co Ltd Recent Developments
  13. 4.3 Yoshindo
  14. 4.3.1 Yoshindo Company Information
  15. 4.3.2 Yoshindo Business Overview
  16. 4.3.3 Yoshindo Beraprost Sodium Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Yoshindo Beraprost Sodium Product Portfolio
  18. 4.3.5 Yoshindo Recent Developments
  19. 4.4 Viatris
  20. 4.4.1 Viatris Company Information
  21. 4.4.2 Viatris Business Overview
  22. 4.4.3 Viatris Beraprost Sodium Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Viatris Beraprost Sodium Product Portfolio
  24. 4.4.5 Viatris Recent Developments
  25. 4.5 Toray
  26. 4.5.1 Toray Company Information
  27. 4.5.2 Toray Business Overview
  28. 4.5.3 Toray Beraprost Sodium Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Toray Beraprost Sodium Product Portfolio
  30. 4.5.5 Toray Recent Developments
  31. 4.6 Taide Pharma
  32. 4.6.1 Taide Pharma Company Information
  33. 4.6.2 Taide Pharma Business Overview
  34. 4.6.3 Taide Pharma Beraprost Sodium Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Taide Pharma Beraprost Sodium Product Portfolio
  36. 4.6.5 Taide Pharma Recent Developments
  37. 4.7 Shin Poong Pharmaceutical
  38. 4.7.1 Shin Poong Pharmaceutical Company Information
  39. 4.7.2 Shin Poong Pharmaceutical Business Overview
  40. 4.7.3 Shin Poong Pharmaceutical Beraprost Sodium Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Shin Poong Pharmaceutical Beraprost Sodium Product Portfolio
  42. 4.7.5 Shin Poong Pharmaceutical Recent Developments
  43. 4.8 Sawai Pharmaceutical
  44. 4.8.1 Sawai Pharmaceutical Company Information
  45. 4.8.2 Sawai Pharmaceutical Business Overview
  46. 4.8.3 Sawai Pharmaceutical Beraprost Sodium Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Sawai Pharmaceutical Beraprost Sodium Product Portfolio
  48. 4.8.5 Sawai Pharmaceutical Recent Developments
  49. 4.9 Ohara Inc
  50. 4.9.1 Ohara Inc Company Information
  51. 4.9.2 Ohara Inc Business Overview
  52. 4.9.3 Ohara Inc Beraprost Sodium Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Ohara Inc Beraprost Sodium Product Portfolio
  54. 4.9.5 Ohara Inc Recent Developments
  55. 4.10 Nihon Generic Co Ltd
  56. 4.10.1 Nihon Generic Co Ltd Company Information
  57. 4.10.2 Nihon Generic Co Ltd Business Overview
  58. 4.10.3 Nihon Generic Co Ltd Beraprost Sodium Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Nihon Generic Co Ltd Beraprost Sodium Product Portfolio
  60. 4.10.5 Nihon Generic Co Ltd Recent Developments
  61. 4.11 Nichiiko
  62. 4.11.1 Nichiiko Company Information
  63. 4.11.2 Nichiiko Business Overview
  64. 4.11.3 Nichiiko Beraprost Sodium Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Nichiiko Beraprost Sodium Product Portfolio
  66. 4.11.5 Nichiiko Recent Developments
  67. 4.12 NABIQASIM INDUSTRIES
  68. 4.12.1 NABIQASIM INDUSTRIES Company Information
  69. 4.12.2 NABIQASIM INDUSTRIES Business Overview
  70. 4.12.3 NABIQASIM INDUSTRIES Beraprost Sodium Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 NABIQASIM INDUSTRIES Beraprost Sodium Product Portfolio
  72. 4.12.5 NABIQASIM INDUSTRIES Recent Developments
  73. 4.13 Lupin Laboratories
  74. 4.13.1 Lupin Laboratories Company Information
  75. 4.13.2 Lupin Laboratories Business Overview
  76. 4.13.3 Lupin Laboratories Beraprost Sodium Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Lupin Laboratories Beraprost Sodium Product Portfolio
  78. 4.13.5 Lupin Laboratories Recent Developments
  79. 4.14 KYOUSOUMIRAI PHARM
  80. 4.14.1 KYOUSOUMIRAI PHARM Company Information
  81. 4.14.2 KYOUSOUMIRAI PHARM Business Overview
  82. 4.14.3 KYOUSOUMIRAI PHARM Beraprost Sodium Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 KYOUSOUMIRAI PHARM Beraprost Sodium Product Portfolio
  84. 4.14.5 KYOUSOUMIRAI PHARM Recent Developments
  85. 4.15 Kyorin Holding
  86. 4.15.1 Kyorin Holding Company Information
  87. 4.15.2 Kyorin Holding Business Overview
  88. 4.15.3 Kyorin Holding Beraprost Sodium Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Kyorin Holding Beraprost Sodium Product Portfolio
  90. 4.15.5 Kyorin Holding Recent Developments
  91. 4.16 Kaken Pharmaceutical
  92. 4.16.1 Kaken Pharmaceutical Company Information
  93. 4.16.2 Kaken Pharmaceutical Business Overview
  94. 4.16.3 Kaken Pharmaceutical Beraprost Sodium Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Kaken Pharmaceutical Beraprost Sodium Product Portfolio
  96. 4.16.5 Kaken Pharmaceutical Recent Developments
  97. 4.17 Astellas Pharma
  98. 4.17.1 Astellas Pharma Company Information
  99. 4.17.2 Astellas Pharma Business Overview
  100. 4.17.3 Astellas Pharma Beraprost Sodium Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Astellas Pharma Beraprost Sodium Product Portfolio
  102. 4.17.5 Astellas Pharma Recent Developments
  103. 4.18 Alfresa Pharma
  104. 4.18.1 Alfresa Pharma Company Information
  105. 4.18.2 Alfresa Pharma Business Overview
  106. 4.18.3 Alfresa Pharma Beraprost Sodium Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Alfresa Pharma Beraprost Sodium Product Portfolio
  108. 4.18.5 Alfresa Pharma Recent Developments
5 Global Beraprost Sodium Market Scenario by Region
  1. 5.1 Global Beraprost Sodium Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Beraprost Sodium Sales by Region: 2021-2032
  3. 5.2.1 Global Beraprost Sodium Sales by Region: 2021-2026
  4. 5.2.2 Global Beraprost Sodium Sales by Region: 2027-2032
  5. 5.3 Global Beraprost Sodium Revenue by Region: 2021-2032
  6. 5.3.1 Global Beraprost Sodium Revenue by Region: 2021-2026
  7. 5.3.2 Global Beraprost Sodium Revenue by Region: 2027-2032
  8. 5.4 North America Beraprost Sodium Market Facts & Figures by Country
  9. 5.4.1 North America Beraprost Sodium Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Beraprost Sodium Sales by Country (2021-2032)
  11. 5.4.3 North America Beraprost Sodium Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Beraprost Sodium Market Facts & Figures by Country
  16. 5.5.1 Europe Beraprost Sodium Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Beraprost Sodium Sales by Country (2021-2032)
  18. 5.5.3 Europe Beraprost Sodium Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Beraprost Sodium Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Beraprost Sodium Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Beraprost Sodium Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Beraprost Sodium Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Beraprost Sodium Market Facts & Figures by Country
  41. 5.7.1 South America Beraprost Sodium Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Beraprost Sodium Sales by Country (2021-2032)
  43. 5.7.3 South America Beraprost Sodium Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Beraprost Sodium Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Beraprost Sodium Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Beraprost Sodium Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Beraprost Sodium Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Beraprost Sodium Sales by Type (2021-2032)
  2. 6.1.1 Global Beraprost Sodium Sales by Type (2021-2032) & (k pcs)
  3. 6.1.2 Global Beraprost Sodium Sales Market Share by Type (2021-2032)
  4. 6.2 Global Beraprost Sodium Revenue by Type (2021-2032)
  5. 6.2.1 Global Beraprost Sodium Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Beraprost Sodium Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Beraprost Sodium Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Beraprost Sodium Sales by Application (2021-2032)
  2. 7.1.1 Global Beraprost Sodium Sales by Application (2021-2032) & (k pcs)
  3. 7.1.2 Global Beraprost Sodium Sales Market Share by Application (2021-2032)
  4. 7.2 Global Beraprost Sodium Revenue by Application (2021-2032)
  5. 7.2.1 Global Beraprost Sodium Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Beraprost Sodium Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Beraprost Sodium Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Beraprost Sodium Value Chain Analysis
  2. 8.1.1 Beraprost Sodium Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Beraprost Sodium Production Mode & Process
  5. 8.2 Beraprost Sodium Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Beraprost Sodium Distributors
  8. 8.2.3 Beraprost Sodium Customers
9 Global Beraprost Sodium Analyzing Market Dynamics
  1. 9.1 Beraprost Sodium Industry Trends
  2. 9.2 Beraprost Sodium Industry Drivers
  3. 9.3 Beraprost Sodium Industry Opportunities and Challenges
  4. 9.4 Beraprost Sodium Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst